TW201018676A - Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same - Google Patents

Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same Download PDF

Info

Publication number
TW201018676A
TW201018676A TW098135851A TW98135851A TW201018676A TW 201018676 A TW201018676 A TW 201018676A TW 098135851 A TW098135851 A TW 098135851A TW 98135851 A TW98135851 A TW 98135851A TW 201018676 A TW201018676 A TW 201018676A
Authority
TW
Taiwan
Prior art keywords
group
compound
salt
atom
alkyl
Prior art date
Application number
TW098135851A
Other languages
English (en)
Chinese (zh)
Inventor
Keigo Tanaka
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of TW201018676A publication Critical patent/TW201018676A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
TW098135851A 2008-10-24 2009-10-22 Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same TW201018676A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10820108P 2008-10-24 2008-10-24
JP2008274060 2008-10-24

Publications (1)

Publication Number Publication Date
TW201018676A true TW201018676A (en) 2010-05-16

Family

ID=42118103

Family Applications (1)

Application Number Title Priority Date Filing Date
TW098135851A TW201018676A (en) 2008-10-24 2009-10-22 Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same

Country Status (16)

Country Link
US (2) US8188119B2 (ja)
EP (1) EP2351752A4 (ja)
JP (1) JPWO2010047120A1 (ja)
KR (1) KR20110069823A (ja)
CN (1) CN102186846A (ja)
AU (1) AU2009307574A1 (ja)
BR (1) BRPI0920614A2 (ja)
CA (1) CA2740982A1 (ja)
IL (1) IL211980A0 (ja)
MX (1) MX2011003389A (ja)
NZ (1) NZ592416A (ja)
PE (1) PE20120024A1 (ja)
RU (1) RU2011116160A (ja)
TW (1) TW201018676A (ja)
WO (1) WO2010047120A1 (ja)
ZA (1) ZA201102840B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7932272B2 (en) * 2003-09-30 2011-04-26 Eisai R&D Management Co., Ltd. Antifungal agent containing heterocyclic compound
TWI385169B (zh) * 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
WO2008035726A1 (fr) 2006-09-21 2008-03-27 Eisai R & D Management Co., Ltd. Dérivé de pyridine substitué par un cycle hétéroaryle, et agent antifongique le comprenant
TW200841879A (en) * 2007-04-27 2008-11-01 Eisai R&D Man Co Ltd Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
US8513287B2 (en) * 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
EP2345328A4 (en) * 2008-09-19 2014-06-25 Sumitomo Chemical Co COMPOSITION FOR USE IN AGRICULTURE
US8188119B2 (en) * 2008-10-24 2012-05-29 Eisai R&D Management Co., Ltd Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
JP2012176900A (ja) * 2009-06-24 2012-09-13 Eisai R & D Management Co Ltd （（ホスホノオキシ）メチル）ピリジニウム環を有するピリジン誘導体およびそれらを含有する抗真菌剤
WO2011051198A2 (de) 2009-10-30 2011-05-05 Bayer Cropscience Ag Pyridin-derivate als pflanzenschutzmittel
JP6134478B2 (ja) 2012-03-28 2017-05-24 ソニー株式会社 情報処理装置、表示制御方法、プログラムおよび記憶媒体
WO2015027067A2 (en) * 2013-08-23 2015-02-26 Virginia Commonwealth University Ester nitrates derivatives of aromatic aldehydes with multiple pharmalogic properties to treat sickle cell disease
CN111698989B (zh) 2017-12-07 2023-08-01 安普利克斯制药公司 杂环取代的吡啶衍生物抗真菌剂
CN112638371A (zh) * 2018-06-25 2021-04-09 安普利克斯制药公司 被杂环和氨基取代的吡啶衍生物
EP3886854A4 (en) 2018-11-30 2022-07-06 Nuvation Bio Inc. PYRROLE AND PYRAZOLE COMPOUNDS AND METHODS OF USE THERE
JP7156154B2 (ja) * 2019-04-18 2022-10-19 株式会社島津製作所 培地処理システム及び培地処理方法
CN113484308B (zh) * 2021-06-25 2023-01-03 兰州大学 一种快速鉴别真假葡萄酒的试纸及其制备和应用

Family Cites Families (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB919073A (en) 1960-09-15 1963-02-20 Farmaceutici Italia Benzylamine derivatives
JPS542325A (en) 1977-06-07 1979-01-09 Sankyo Co Ltd Agricultural and horticultural pesticide
US4551532A (en) 1980-05-08 1985-11-05 Takeda Chemical Industries, Ltd. Ethylene glycol derivatives having anti-protozoan, anti-fungal and anti-tumor activity
JPS57179192A (en) 1981-04-27 1982-11-04 Takeda Chem Ind Ltd Ethylene glycol derivative
JPS5973575A (ja) * 1982-10-05 1984-04-25 Shionogi & Co Ltd プロピニルアミノイソオキサゾ−ル誘導体
JPS5984824A (ja) 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
GB8311003D0 (en) 1983-04-22 1983-05-25 Shell Int Research Aniline compounds
EP0124067B1 (de) 1983-05-04 1986-12-17 CASSELLA Aktiengesellschaft 2-(Aminoalkyl)-pyrrol-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3316187A1 (de) 1983-05-04 1984-11-08 Cassella Ag, 6000 Frankfurt 2-(aminomethyl)-pyrrol-derivate, verfahren zu ihrer herstellung und ihre verwendung
WO1986003203A1 (en) 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Thienylthiazole derivatives
JP2556849B2 (ja) 1986-02-13 1996-11-27 三共株式会社 グリセリン誘導体
US5070082A (en) * 1986-10-23 1991-12-03 American Cyanamid Company Solubilized pro-drugs
US4851423A (en) 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
DE68904203D1 (de) 1988-01-25 1993-02-18 Santen Pharmaceutical Co Ltd Cysteinderivate.
IL89028A0 (en) * 1988-01-29 1989-08-15 Lilly Co Eli Quinoline,quinazoline and cinnoline derivatives
US5034393A (en) 1989-07-27 1991-07-23 Dowelanco Fungicidal use of pyridopyrimidine, pteridine, pyrimidopyrimidine, pyrimidopyridazine, and pyrimido-1,2,4-triazine derivatives
JPH03161470A (ja) 1989-11-17 1991-07-11 Nisshin Flour Milling Co Ltd インドール誘導体
JPH05294935A (ja) * 1991-03-15 1993-11-09 Green Cross Corp:The アミノピリジン系化合物
US5371086A (en) * 1991-03-15 1994-12-06 The Green Cross Corporation Aminopyridine compounds
US5208247A (en) * 1991-08-01 1993-05-04 American Cyanamid Company Pyridinium compounds which are useful as antagonists of platelet activating factor
EP0533130A1 (de) 1991-09-19 1993-03-24 Hoechst Aktiengesellschaft 2-Hydroxymethylpyridine, die entsprechenden Pyridin-N-oxide und ihre Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung
CA2121696C (en) * 1991-10-23 2003-07-08 James R. Lupski Fingerprinting bacterial strains using repetitive dna sequence amplification
SE9103776D0 (sv) 1991-12-19 1991-12-19 Astra Ab New compounds
WO1995009159A1 (en) 1993-09-28 1995-04-06 Otsuka Pharmaceutical Company, Limited Quinoxaline derivative as antidiabetic agent
AU677502B2 (en) 1994-01-07 1997-04-24 Dowelanco N-(4-pyrimidinyl)amide pesticides
IL112778A0 (en) * 1994-03-04 1995-05-26 Merck & Co Inc Substituted heterocycles, their preparation and pharmaceutical compositions containing them
DE4434637A1 (de) * 1994-09-28 1996-04-04 Hoechst Schering Agrevo Gmbh Substituierte Pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide
JPH08175993A (ja) * 1994-12-21 1996-07-09 Green Cross Corp:The 抗酸化剤
EP0737682B1 (en) * 1995-04-11 2002-01-09 Mitsui Chemicals, Inc. Substituted thiophene derivative and agricultural and horticultural fungicide containing the same as active ingredient
US5710171A (en) * 1995-05-24 1998-01-20 Merck & Co., Inc. Bisphenyl inhibitors of farnesyl-protein transferase
US6080767A (en) * 1996-01-02 2000-06-27 Aventis Pharmaceuticals Products Inc. Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
EP0880501A1 (en) * 1996-02-02 1998-12-02 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
US5945431A (en) * 1996-03-15 1999-08-31 Biochem Therapeutics Incorporated Cytomegalovirus inhibiting compounds
GB9605437D0 (en) 1996-03-15 1996-05-15 Iaf Biochem Int Cytomegalovirus inhibiting compounds
EP0796619A1 (en) * 1996-03-21 1997-09-24 Merrell Pharmaceuticals Inc. Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol in treating depressive disorders and bipolar disorders
US6080757A (en) * 1996-06-06 2000-06-27 Pfizer Inc Antibiotic quinolones and derivatives
US6174905B1 (en) * 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer
BR9810733A (pt) * 1997-04-04 2000-09-12 Pfizer Prod Inc Derivados de nicotinamida
US20020111495A1 (en) * 1997-04-04 2002-08-15 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
AU732455C (en) * 1997-05-08 2002-09-05 Merck Sharp & Dohme Limited Substituted 1,2,4-triazolo{3,4-a}phthalazine derivatives as gaba alpha 5 ligands
DE19727117A1 (de) 1997-06-26 1999-01-07 Boehringer Ingelheim Pharma Phenylalkylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE19732033A1 (de) * 1997-07-25 1999-01-28 Bayer Ag Triazolinthion-phosphorsäure-Derivate
AU9002598A (en) * 1997-09-16 1999-04-05 Takeda Chemical Industries Ltd. Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs
US6022884A (en) * 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use
WO1999029318A1 (en) * 1997-12-11 1999-06-17 Biochem Pharma Inc. Antiviral compounds
DE69822514T2 (de) 1997-12-31 2005-03-24 The University Of Kansas, Lawrence Wasserlösliche pro-pharmaka von arzneistoffen, die ein tertiäres amin enthalten, und verfahren zu ihrer herstellung
PE20000942A1 (es) 1998-07-31 2000-09-28 Lilly Co Eli Derivados de amida, carbamato y urea
JP2000178243A (ja) 1998-12-14 2000-06-27 Teijin Ltd ビフェニルアミジン誘導体
US6235728B1 (en) * 1999-02-19 2001-05-22 Bristol-Myers Squibb Company Water-soluble prodrugs of azole compounds
WO2000050424A1 (en) * 1999-02-22 2000-08-31 Biochem Pharma Inc. [1,8] naphthyridine derivatives having antiviral activity
US6319944B1 (en) 1999-05-10 2001-11-20 Merck & Co., Inc. Aryl amidines, compositions containing such compounds and methods of use
GB9919588D0 (en) 1999-08-18 1999-10-20 Hoechst Schering Agrevo Gmbh Fungicidal compounds
TWI262185B (en) 1999-10-01 2006-09-21 Eisai Co Ltd Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
JP4831907B2 (ja) 1999-10-08 2011-12-07 アフィニアム・ファーマシューティカルズ・インコーポレイテッド ＦａｂＩ阻害剤
AU1607501A (en) 1999-11-15 2001-05-30 Drug Innovation & Design, Inc. Selective cellular targeting: multifunctional delivery vehicles
US6414013B1 (en) * 2000-06-19 2002-07-02 Pharmacia & Upjohn S.P.A. Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
US6513676B2 (en) * 2000-06-21 2003-02-04 Martin L. Clemmons Universal cup holder with food tray accessories
CN100467597C (zh) * 2000-07-07 2009-03-11 卫材R&D管理有限公司 真菌细胞壁合成基因
JP4097194B2 (ja) 2000-07-07 2008-06-11 エーザイ・アール・アンド・ディー・マネジメント株式会社 真菌の細胞壁合成遺伝子
CA2419219A1 (en) * 2000-09-15 2002-03-21 Anormed Inc. Chemokine receptor binding heterocyclic compounds
WO2002022583A2 (en) * 2000-09-18 2002-03-21 E. I. Du Pont De Nemours And Company Pyridinyl amides and imides for use as fungicides
EP1217000A1 (en) 2000-12-23 2002-06-26 Aventis Pharma Deutschland GmbH Inhibitors of factor Xa and factor VIIa
EP1229034B1 (en) 2001-01-31 2005-04-13 Pfizer Products Inc. Nicotinamide derivatives and their mimetics as inhibitors of PDE4 isozymes
JP2002275159A (ja) 2001-03-16 2002-09-25 Japan Tobacco Inc Ｈｃｐ阻害剤及びｈｃｐ阻害活性を有する化合物
PT1373263E (pt) 2001-04-05 2005-03-31 Torrent Pharmaceuticals Ltd Compostos heterociclicos para complicacoes relacionadas com a idade e complicacoes vasculares diabeticas
GB0109122D0 (en) * 2001-04-11 2001-05-30 Smithkline Beecham Spa Novel compounds
EP1275301A1 (en) 2001-07-10 2003-01-15 Bayer CropScience S.A. Trisubstituted heterocyclic compounds and their use as fungicides
EP1275653A1 (en) 2001-07-10 2003-01-15 Bayer CropScience S.A. Oxazolopyridines and their use as fungicides
EP1578898A2 (en) 2001-07-13 2005-09-28 Virtual Drug Development, Inc. Nad synthetase inhibitors and uses thereof
US20040198773A1 (en) * 2001-09-26 2004-10-07 Barry Hart Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitors
KR100437972B1 (ko) * 2001-10-27 2004-07-02 한국과학기술연구원 피롤리디논 유도체, 이의 제조 방법 및 이를 포함하는제약 조성물
EP2336133A1 (en) 2001-10-30 2011-06-22 Conforma Therapeutics Corporation Purine analogs having HSP90-inhibiting activity
ATE391505T1 (de) * 2001-11-27 2008-04-15 Hoffmann La Roche Benzothiazole derivative
AU2002352868A1 (en) 2001-11-27 2003-06-10 Merck & Co., Inc. 4-aminoquinoline compounds
US20030191158A1 (en) * 2002-02-11 2003-10-09 Magee Thomas V. Nicotinamide derivatives and a tiotropium salt in combination for the treatment of diseases
BRPI0307351B8 (pt) 2002-02-12 2021-05-25 Smithkline Beecham Corp composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto
CN100361578C (zh) * 2002-03-08 2008-01-16 巴斯福股份公司 基于Prothioconazole并含有杀虫剂的杀真菌混合物
MXPA04008999A (es) * 2002-03-20 2004-12-07 Squibb Bristol Myers Co Profarmacos de fosfato de fluorooxindoles.
DE60321907D1 (de) * 2002-04-26 2008-08-14 Lilly Co Eli Tachykininrezeptorantagonisten
EP1369420A1 (en) 2002-06-06 2003-12-10 Aventis Pharma Deutschland GmbH Inhibitors of the GPib - vWF interaction
AU2003244181A1 (en) 2002-06-25 2004-01-06 Yamanouchi Pharmaceutical Co., Ltd. Phenoxypyridine derivative or salt thereof
EP1536790A2 (en) 2002-08-09 2005-06-08 AstraZeneca AB Oxadiazoles as modulators of metabotropic glutamate receptor-5
PA8578101A1 (es) 2002-08-13 2004-05-07 Warner Lambert Co Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz
GB0222495D0 (en) 2002-09-27 2002-11-06 Glaxo Group Ltd Compounds
AU2003271117A1 (en) 2002-10-09 2004-05-04 Ssp Co., Ltd. Novel pyrazole compounds having antifungal activity
KR100933759B1 (ko) 2002-11-22 2009-12-23 에자이 알앤드디 매니지먼트 가부시키가이샤 말라리아 기생충에서 ｇｐｉ의 생합성을 억제하는 화합물을스크리닝하는 방법
WO2004052280A2 (en) 2002-12-10 2004-06-24 Imclone Systems Incorporated Anti-angiogenic compounds and their use in cancer treatment
JP4896518B2 (ja) * 2002-12-13 2012-03-14 ワイエム・バイオサイエンシズ・オーストラリア・ピーティーワイ・リミテッド ニコチンアミド系キナーゼ阻害薬
TW200500360A (en) 2003-03-01 2005-01-01 Astrazeneca Ab Hydroxymethyl compounds
DE10315572A1 (de) 2003-04-05 2004-10-14 Merck Patent Gmbh Substituierte Pyrazole
JP4156460B2 (ja) 2003-07-09 2008-09-24 Ｔｄｋ株式会社 ワークのピックアップ方法及びその装置、実装機
BRPI0412918A (pt) * 2003-07-25 2006-09-26 Novartis Ag inibidores de quinases p38
US7932272B2 (en) * 2003-09-30 2011-04-26 Eisai R&D Management Co., Ltd. Antifungal agent containing heterocyclic compound
EP1782811A4 (en) 2004-08-09 2010-09-01 Eisai R&D Man Co Ltd INNOVATIVE ANTIPALUDITIC AGENT CONTAINING A HETEROCYCLIC COMPOUND
US20090227799A1 (en) 2004-08-09 2009-09-10 Kazutaka Nakamoto Novel Antimalarial Agent Containing Heterocyclic Compound
EP1864980A4 (en) * 2005-03-30 2010-08-18 Eisai R&D Man Co Ltd A PYRIDINE DERIVATIVE ANTIPILIC AGENT
CA2626767C (en) 2005-10-31 2012-01-17 Eisai R&D Management Co., Ltd. Heterocyclic substituted pyridine derivatives and antifungal agent containing same
TWI385169B (zh) * 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
US20070099877A1 (en) 2005-11-02 2007-05-03 Cytovia, Inc. N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
WO2008035726A1 (fr) * 2006-09-21 2008-03-27 Eisai R & D Management Co., Ltd. Dérivé de pyridine substitué par un cycle hétéroaryle, et agent antifongique le comprenant
TW200841879A (en) * 2007-04-27 2008-11-01 Eisai R&D Man Co Ltd Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
EP2143723A4 (en) 2007-04-27 2011-05-18 Eisai R&D Man Co Ltd SALT OF A PYRIDINE DERIVATIVE SUBSTITUTED BY HETEROCYCLE OR CRYSTALS OF THE SAME
EP2226320A4 (en) 2007-12-26 2012-07-11 Eisai R&D Man Co Ltd PROCESS FOR THE PRODUCTION OF A HETEROCYCLE-SUBSTITUTED PYRIDINE DERIVATIVE
US8513287B2 (en) * 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
US8188119B2 (en) * 2008-10-24 2012-05-29 Eisai R&D Management Co., Ltd Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
JP2012176900A (ja) 2009-06-24 2012-09-13 Eisai R & D Management Co Ltd （（ホスホノオキシ）メチル）ピリジニウム環を有するピリジン誘導体およびそれらを含有する抗真菌剤

Also Published As

Publication number Publication date
ZA201102840B (en) 2011-12-28
EP2351752A4 (en) 2012-05-30
CA2740982A1 (en) 2010-04-29
US20100105737A1 (en) 2010-04-29
KR20110069823A (ko) 2011-06-23
EP2351752A1 (en) 2011-08-03
MX2011003389A (es) 2011-04-21
CN102186846A (zh) 2011-09-14
PE20120024A1 (es) 2012-02-22
US20120277439A1 (en) 2012-11-01
RU2011116160A (ru) 2012-11-27
BRPI0920614A2 (pt) 2015-12-22
JPWO2010047120A1 (ja) 2012-03-22
IL211980A0 (en) 2011-06-30
WO2010047120A1 (ja) 2010-04-29
US8188119B2 (en) 2012-05-29
AU2009307574A1 (en) 2010-04-29
NZ592416A (en) 2011-12-22

Similar Documents

Publication Publication Date Title
TW201018676A (en) Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
CA2666563C (en) Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
CN104379574B (zh) 用于抑制abl1、abl2和bcr‑abl1的活性的苯甲酰胺衍生物
CN104302638B (zh) 用于抑制abl1、abl2和bcr-abl1的活性的苯甲酰胺衍生物
TWI358296B (en) Acid secretion inhibitor
EP3284738B1 (en) 5-aromatic alkynyl substituted benzamide compound and preparation method, pharmaceutical composition, and use thereof
CN104395309B (zh) 环状桥头醚dgat1抑制剂
TW200934788A (en) Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
CA2729275A1 (en) 5- and 6-membered heterocyclic compounds
TW200831509A (en) Inhibitors of Akt activity
KR20080000622A (ko) 신규한 옥사디아졸 유도체 및 이의 의학적 용도
WO2013036232A2 (en) Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
TW201116276A (en) Glycine compounds
CN111225917A (zh) 取代咪唑并吡啶酰胺及其用途
KR20170123693A (ko) 그렐린 o-아실 트랜스퍼라제 억제제
WO2016084866A1 (ja) 新規ジアザビシクロ誘導体
TW201031658A (en) Inhibitors of diacylglycerol acyltransferase
KR20170123694A (ko) 그렐린 o-아실 트랜스퍼라제 억제제
WO2016088813A1 (ja) 新規ジアザビシクロ［２．２．２］オクタン誘導体
CA2954583C (en) Benzodiazepine derivatives as cck2/gastrin receptor antagonists
TW200831505A (en) Polycyclic agents for the treatment of respiratory syncytial virus infections
JP2021527636A (ja) Ｅａａｔ２活性化因子およびその使用方法
CA2887887A1 (en) Pyrazolopyridine derivatives as ttx-s blockers
US9879004B2 (en) Substituted acetylene derivatives and their use as positive allosteric modulators of mGluR4
WO2011070299A1 (fr) DERIVES DE 9H-BETA-CARBOLINE (OU 9H-PYRIDINO[3,4-b]INDOLE) TRISUBSTITUES, LEUR PREPARATION ET LEUR UTILISATION THERAPEUTIQUE